ITMCTR2100004284
Recruiting
Phase 4
A randomized, double-blind, parallel-controlled, multicentre clinical study to evaluate the efficacy and safety of Sechang Zhixie Powder in the treatment of acute watery diarrhea in children
First Teaching Hospital of Tianjin University of TCM0 sitesTBD
ConditionsAcute watery diarrhea
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Acute watery diarrhea
- Sponsor
- First Teaching Hospital of Tianjin University of TCM
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients meeting the diagnostic criteria of acute watery stool diarrhea;
- •2\. Patients aged 1\-5 years (\< 6 years);
- •3\. Patients with diarrhea duration \<\= 72 hours;
- •4\. Patients without dehydration or mild or moderate dehydration;
- •5\. Accompanied with abdominal pain (essential for children over 3 years old);
- •6\. The process of informed consent should meet the requirements, and the guardian should sign the informed consent.
Exclusion Criteria
- •1\. Patients with invasive bacterial infectious diarrhea / dysentery like diarrhea, such as mucus, purulent stool, or stool microscopic examination found that the number of pus / white blood cells \>\= 5 / HP and / or red blood cells \>\= 3 / HP;
- •2\. Diarrhea caused by special pathogens (such as cholera, dysentery, typhoid), anatomical defects or congenital factors (such as Hirschsprung's disease, malabsorption syndrome), other diseases (such as inflammatory bowel disease, endocrine disease), symptomatic diarrhea, allergic diarrhea, irritable bowel syndrome, antibiotic associated diarrhea, food poisoning, etc;
- •3\. Patients with severe dehydration, severe malnutrition or edema, frequent vomiting and inability to eat;
- •4\. Patients with serious primary diseases such as heart, liver, kidney, digestive and hematopoietic system;
- •5\. Patients who are allergic to the test drug and its components;
- •6\. The researchers believe that there are any patients who are not suitable for inclusion or have factors affecting the participation or completion of the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A randomized, double-blind, parallel-controlled, multicenter trial to evaluate the effectiveness and safety of Xiyanping injection combined with azithromycin and azithromycin in the treatment of mycoplasma pneumoniae pneumonia in childreMycoplasma pneumoniae pneumoniaITMCTR2000003093The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Recruiting
Phase 4
A randomized, double-blind, parallel-controlled, multi-center clinical trial of Chinese medicine variety protection with Niuhuang Qinggan Capsule in the treatment of common cold (wind-heat syndrome)Common cold (wind-heat syndrome)ITMCTR2200005537The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine
Recruiting
Phase 4
A randomized, double-blind, parallel-controlled, multi-center clinical trial of traditional Chinese medicine variety protection with Wuhu Oral Liquid in the treatment of acute soft tissue injury (Qi stagnation and blood stasis syndrome)acute soft tissue injuryITMCTR2200005606onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Not yet recruiting
Phase 1
A randomized, double-blind, parallel-controlled, multi-center clinical trial of the effectiveness and safety of Fuyanxiao Capsule in the treatment of pelvic inflammatory diseases (damp-heat stasis syndrome)ITMCTR2100005028Dongfang Hospital, Beijing University of Chinese Medicine
Recruiting
Phase 2
Phase II Clinical Trial of Qingke Pingchuan Granules in Treating Acute Bronchitis in ChildreAcute bronchitis in childrenITMCTR2100004581Shanghai Traditional Chinese Medicine Hospital